期刊文献+

前列腺癌患者血清tPSA、f/tPSA与Gleason评分的关系及其诊断价值 被引量:1

Relationship between serum tPSA,f/tPSA and Gleason score in patients with prostate cancer and its diagnostic value
下载PDF
导出
摘要 目的探讨前列腺癌患者血清人总前列腺特异性抗原(tPSA)、游离前列腺特异性抗原/总前列腺特异性抗原(f/tPSA)的变化与Gleason评分的关系及其诊断学价值。方法选取2018年2月至2020年4月浙江省台州市立医院确诊的前列腺癌(PCa)患者90例(PCa组)、前列腺良性疾病患者90例(对照组),检测两组对象的血清tPSA、f/tPSA水平;分析不同Gleason评分的PCa患者血清tPSA、f/tPSA水平差异,并采用受试者工作曲线(ROC)分析上述两项指标诊断PCa的临床价值。结果PCa组患者血清tPSA高于对照组,差异有统计学意义(P<0.05),f/tPSA低于对照组,差异有统计学意义(P<0.05);Gleason评分>7分PCa组患者血清tSPA水平显著高于Gleason评分≤7分者,差异有统计学意义(P<0.05);tPSA诊断PCa敏感度为79.29%,特异度为71.61%,AUC值为0.848;f/tPSA诊断PCa敏感度为70.30%,特异度为74.53%,AUC值为0.774。结论血清tPSA、f/tPSA水平检测对于诊断PCa有一定的临床价值,血清tPSA水平变化与Gleason评分有一定的关系。 Objective To investigate the relationship between the changes of serum human total prostate-specific antigen(tPSA),free prostate-specific antigen/total prostate-specific antigen(f/tPSA)and Gleason score and their diagnostic value in prostate cancer patients.Methods The retrospective research method was adopted in this study,90 patients with prostate cancer(PCa)diagnosed in our hospital from February 2018 to April 2020(PCa group)and 90 patients with benign prostate diseases were selected as the control group,and the two groups were tested.The serum tPSA and f/tPSA levels of the subjects were analyzed;the differences in serum tPSA and f/tPSA levels of PCa patients with different Gleason scores were analyzed,and the receiver operating curve(ROC)was used to analyze the clinical value of the above two indicators in the diagnosis of PCa.Results The serum tPSA in the PCa group was higher than that in the control group,and the difference was statistically significant(P<0.05),and the f/tPSA was lower than that in the control group,and the difference was statistically significant(P<0.05).Gleason score>7 points in the PCa group The serum tSPA level of the patients was significantly higher than that of the patients with Gleason score≤7 points,and the difference was statistically significant(P<0.05).The sensitivity of PCa was 70.30%,the specificity was 74.53%,and the AUC value was 0.774.Conclusion The detection of serum tPSA and f/tPSA levels has certain clinical value in the diagnosis of PCa.The changes of serum tPSA level have a certain relationship with Gleason score.
作者 徐林飞 张海涛 刘晟 程伟松 林星长 林勇峰 XU Linfei;ZHANG Haitao;LIU Sheng;CHENG Weisong;LIN Xingchang;LIN Yongfeng(Department of Urinary Surgery,Taizhou Municipal Hospital in Zhejiang Province,Taizhou318000,China)
出处 《中国现代医生》 2022年第7期9-12,共4页 China Modern Doctor
基金 浙江省医药卫生科技计划项目(2018KY904) 浙江省台州市第一批社会发展科技计划项目(20ywa33)。
关键词 前列腺癌 TPSA F/TPSA GLEASON评分 Prostate carcinoma tPSA f/tPSA Gleason score
  • 相关文献

参考文献13

二级参考文献88

  • 1肖丽萍,毕向军,李亚南,陈晓清,张晓峰,余新沛,刘岗,杨明常,宋骤.前列腺特异性抗原对前列腺癌早期诊断的价值[J].南方医科大学学报,2007,27(1):107-108. 被引量:10
  • 2Arcangeli C G, Ornstein D K , Keetch D W, et al.Prostate-specific antigen as a screening test for prostate cancer. The United States experience [J]. Urol Clin North Am,1997,24(2) :299-306.
  • 3Reiter W, Stieber P, Schmeller N. The ratio of free to total prostate specific antigen: an advantageous addition in the differential diagnosis of benign hyperplasia and cancer of the prostate[J]? Anticancer Res, 1997, 17(4B): 2987-2991.
  • 4Patel D,White P A E , Milford Ward A. A comparison of six commercial assays for total and free prostate specific antigen(PSA):the predictive value of the ratio of free to total PSA[J]. BJU Int,2000,85(6):686-689.
  • 5Weckermann D, Maassen C, Wawroschek F,et al. Improved discrimination of prostate cancer and benign prostatic hyperplasia by means of the quotient of free and total PSA[J]. Int Urol Nephrol, 1999, 31(3): 351 -359.
  • 6Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates [ J ]. Eur Urol, 2012, 61 (6) : 1079-1092. DOI: 10.1016/j.eururo.2012.02.054.
  • 7Han S J, Zhang SW, Chen WQ, et al. The incidence status quo and trend analysis of prostate cancer of China [ J ]. Journal of Clinical Oncology, 2013, 18 (4) : 330-334. DOI : 10.3969/j. issn. 1009-0460.2013.04.009.
  • 8Na YQ. The Chinese guideline of urology disease diagnosis and treatment[ M ]. Beijing: People' s Medical Publishing House, 2013:61-81.
  • 9Andriole GL, Levin DL, Cmwford ED, et al. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial[ J 1. J Natl Cancer Inst, 2005, 97 (6) : 433-438. DOI : 10.1093/jnci/dji065.
  • 10Crawford ED, DeAntoni EP, Etzioni R, et al. Senun prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council[ J]. Urology, 1996, 47 (6) :863-869. DOI: 10.1016/S0090-4295 (96) 00061-1.

共引文献103

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部